首页> 外文OA文献 >Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR)

【2h】

Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR)

机译：GVAX胰腺（含环磷酰胺）和CRS-207联合或不联合nivolumab在先前治疗过的转移性胰腺腺癌（STELLAR）患者中的安全性，疗效和免疫应答的II期随机研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的II期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11) [J] . Ji-Yeon Kim, Young-Hyuck Im, Tae-Yong Kim, 癌症（英文版） . 2019,第008期
2. Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR) [J] . Dung T Le, Todd S Crocenzi, Jennifer N Urum, Journal for ImmunoTherapy of Cancer . 2015,第S2期

机译：GVAX胰腺（含环磷酰胺）和CRS-207联合或不联合nivolumab在先前治疗过的转移性胰腺腺癌（STELLAR）患者中的安全性，疗效和免疫应答的II期随机研究
3. A Phase IIb, randomized, multicenter study of the efficacy of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with previously-treated metastatic pancreatic adenocarcinoma (eclipse study) [J] . Andrea Wang-Gillam, Vincent Picozzi, Todd Crocenzi, Journal for ImmunoTherapy of Cancer . 2014,第S3期

机译：GVAX胰腺疫苗和CRS-207与化学疗法和CRS-207相比单独在具有先前治疗的转移性胰腺腺癌（Eclipse研究）中的CRS-207（Eclipse研究）相比的疗法，随机多中心研究
4. Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study) [J] . Le Dung T., Picozzi Vincent J., Ko Andrew H., Clinical cancer research: an official journal of the American Association for Cancer Research . 2019,第18期

机译：IIB的结果，随机化，多中心研究GVAX胰腺和CRS-207与具有先前治疗的转移性胰腺腺癌的成人化疗（Eclipse研究）相比
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Randomized Phase II study of the safety efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR) [O] . Dung T Le, Todd S Crocenzi, Jennifer N Urum, 2015

机译：GVAX胰腺（含环磷酰胺）和CRS-207联合或不联合nivolumab在先前治疗过的转移性胰腺腺癌（STELLAR）患者中的安全性疗效和免疫应答的II期随机研究
7. A Phase IIb, randomized, multicenter study of the efficacy of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with previously-treated metastatic pancreatic adenocarcinoma (eclipse study) [O] . 2014

机译：IIb期随机，多中心GVAX胰腺疫苗和CRS-207与先前治疗过的转移性胰腺腺癌的成人相比，化学疗法或单独使用CRS-207的疗效比较（日食研究）

Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR)

著录项

相似文献

相关主题

期刊订阅